Skip to main
RIGL
RIGL logo

Rigel Pharmaceuticals (RIGL) Market Capitalization Overview

Market Cap: $733.10M as of Sep 8, 2025

$733.10M
Past Month+$164.49M (28.93%)
As of Sep 8, 2025, Rigel Pharmaceuticals (RIGL) has a market capitalization of $733.10M. Over the past 30 days, its market cap has increased by 76.17%, while in the last 12 months, it has increased by 147.43%.

Market capitalization represents the total value of Rigel Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Rigel Pharmaceuticals (RIGL) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Rigel Pharmaceuticals (RIGL) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Rigel Pharmaceuticals (RIGL) Market Cap History

DateMarket CapChange
Sep 2, 2025$689.87M+76.17%
Aug 1, 2025$391.59M+17.10%
Jul 1, 2025$334.40M-7.15%
Jun 2, 2025$360.13M+7.67%
May 1, 2025$334.47M+9.18%
Apr 1, 2025$306.36M-22.26%
Mar 3, 2025$394.05M+5.72%
Feb 3, 2025$372.74M+22.17%
Jan 2, 2025$305.10M-35.97%

Rigel Pharmaceuticals (RIGL) End of Year Market Cap History

DateMarket CapChange
2025$733.10M+147.43%
2024$296.29M+17.19%
2023$252.84M-2.48%
2022$259.26M-42.99%
2021$454.75M-23.26%
2020$592.61M

FAQs About Rigel Pharmaceuticals (RIGL) Market Cap

As of Sep 8, 2025, the market capitalization of Rigel Pharmaceuticals (RIGL) is $733.10M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Rigel Pharmaceuticals’s market capitalization has increased by 28.93%, changing from $568.62M to $733.10M as of Sep 8, 2025.

In the last 3 months, Rigel Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Rigel Pharmaceuticals’s market capitalization increased from $252.84M in January to $296.29M in December, reflecting a 17.19% change.

In the past five years, Rigel Pharmaceuticals (RIGL) has had a compound annual growth rate (CAGR) of -12.95% in market capitalization. This means its market cap has shrunk at an average rate of -12.95% per year.

Rigel Pharmaceuticals (RIGL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.